Jamie Troil Goldfarb was diagnosed with Stage II melanoma in 2008. She and her husband worked in clinical trial recruitment, and after the cancer spread to her liver and pancreas (stage IV) in 2011, she joined a clinical trial at the National Cancer Institute (NCI). Crediting the trial with saving her life, she is a research advocate for the NCI, works with the Melanoma Research Alliance, the Melanoma Research Foundation, the Melanoma International Foundation, the Alliance for Regenerative Medicine, the Center for Information and Study on Clinical Research Participation (CISCRP), Imerman Angels (a one-on-one cancer support community), and helps people with cancer navigate their treatment options. She also works with pharmaceutical and biotech companies, helping them create information about clinical trials that is easily understandable by patients, consults on protocol development, and helps uncover the best avenues to reach patients. She speaks across the country about the need to position, and help patients understand, clinical trials as viable treatment options.